In the latest close session, Pfizer (PFE) was down 1.09% at $24.50. This move lagged the S&P 500's daily gain of 0.23%. Meanwhile, the Dow experienced a rise of 0.34%, and the technology-dominated ...

Combinations of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs) are the accepted ...

The democratization of investing started with discount brokers slashing commissions and advanced through no-transaction-fee ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

The lawsuit accuses pharmaceutical companies of “deceptively marketing” Tylenol as a safe option for pregnant mothers.

Royalty Pharma Plc (NASDAQ: RPRX) is one of the most profitable biotech stocks to buy. On October 10, Morgan Stanley analyst ...

Texas AG Ken Paxton sues Johnson & Johnson for allegedly marketing Tylenol to pregnant women despite potential risks to ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Which is the point of generic drugs. They’re brilliant pharmaceutical representations of what’s true in all walks of ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...